KEGG   DRUG: Amatuximab
Entry
D09767                      Drug                                   
Name
Amatuximab (USAN)
Formula
C6394H9870N1694O2024S46
Exact mass
144240.8629
Mol weight
144329.909
Sequence
(Heavy chain)
QVQLQQSGPE LEKPGASVKI SCKASGYSFT GYTMNWVKQS HGKSLEWIGL ITPYNGASSY
NQKFRGKATL TVDKSSSTAY MDLLSLTSED SAVYFCARGG YDGRGFDYWG SGTPVTVSSA
STKGPSVFPL APSSKSTSGG TAALGCLVKD YFPEPVTVSW NSGALTSGVH TFPAVLQSSG
LYSLSSVVTV PSSSLGTQTY ICNVNHKPSN TKVDKKVEPK SCDKTHTCPP CPAPELLGGP
SVFLFPPKPK DTLMISRTPE VTCVVVDVSH EDPEVKFNWY VDGVEVHNAK TKPREEQYNS
TYRVVSVLTV LHQDWLNGKE YKCKVSNKAL PAPIEKTISK AKGQPREPQV YTLPPSRDEL
TKNQVSLTCL VKGFYPSDIA VEWESNGQPE NNYKTTPPVL DSDGSFFLYS KLTVDKSRWQ
QGNVFSCSVM HEALHNHYTQ KSLSLSPGK
(Light chain)
DIELTQSPAI MSASPGEKVT MTCSASSSVS YMHWYQQKSG TSPKRWIYDT SKLASGVPGR
FSGSGSGNSY SLTISSVEAE DDATYYCQQW SKHPLTFGSG TKVEIKRTVA APSVFIFPPS
DEQLKSGTAS VVCLLNNFYP REAKVQWKVD NALQSGNSQE SVTEQDSKDS TYSLSSTLTL
SKADYEKHKV YACEVTHQGL SSPVTKSFNR GEC
(Disulfide bridge: H22-H96, H146-H202, H222-L213, H228-H'228, H231-H'231, H263-H323, H369-H427, H'22-H'96, H'146-H'202, H'222-L'213, H'263-H'323, H'369-H'427, L23-L87, L133-L193, L'23-L'87, L'133-L'193)
  Type
Peptide
Efficacy
Antineoplastic, Anti-mesothelin antibody
  Type
Monoclonal antibody
Target
MSLN [HSA:10232] [KO:K20733]
Brite
Target-based classification of drugs [BR:br08310]
 Not elsewhere classified
  Cellular process
   Membrane trafficking
    MSLN
     D09767  Amatuximab (USAN)
Other DBs
CAS: 931402-35-6
PubChem: 124490507
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system